![Page 1: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/1.jpg)
COCA Conference Call – COCA Conference Call – National Obstetric Grand Rounds: National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza Pandemic (H1N1) 2009 Influenza
and Pregnancyand Pregnancy
The findings and conclusions in this report are those of the author and do not necessarily represent the official position
of the Centers for Disease Control and Prevention.
Denise J. Jamieson, MD MPHDivision of Reproductive Health
Centers for Disease Control and Prevention
Sonja A. Rasmussen, MD, MSNational Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Kevin Ault, MDDepartment of Gynecology & Obstetrics
Emory University School of Medicine
![Page 2: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/2.jpg)
Continuing Education Disclaimer
In compliance with continuing education requirements, all presenters must disclose any financial or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, and our presenters wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. This presentation does not involve the unlabeled use of a product or product under investigational use.
There is no commercial support.
![Page 3: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/3.jpg)
Accrediting Statements• CME: The Centers for Disease Control and Prevention is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Centers for Disease Control and Prevention designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
• CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1 contact hour.
• CEU: The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 8405 Greensboro Drive, Suite 800, McLean, VA 22102. The CDC is authorized by IACET to offer 0.1 CEU's for this program.
• CECH: The Centers for Disease Control and Prevention is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is a designated event for the CHES to receive 1 Category I contact hour in health education, CDC provider number GA0082.
![Page 4: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/4.jpg)
National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and
Pregnancy
•Overview of influenza (Dr. Jamieson)
•Infection Control Guidance (Dr. Jamieson)
•Testing and Treatment (Dr. Rasmussen)
•Vaccination (Dr. Rasmussen)
•The Atlanta Experience (Dr. Ault)
![Page 5: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/5.jpg)
• No evidence that they are more susceptible
• Increased mortality from influenza during previous pandemics (1918 & 1957)
• Increased risk of complications related to seasonal influenza
Pregnant women at increased risk for Pregnant women at increased risk for severe influenza illnesssevere influenza illness
![Page 6: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/6.jpg)
1.72.1
5.1
0
2
4
6
8
1st trimester 2nd trimester 3rd trimester
Rat
e R
atio
sRisk of Hospital Admission for Respiratory Illness
during Influenza Season by Pregnancy Status* among Women with No Comorbidity,
Nova Scotia, 1990-2002
Dodds et al., CMAJ 176:463-8, 2007
*Compared to year before pregnancy
![Page 7: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/7.jpg)
• Mechanical, hormonal, immunologic alterations in pregnancy
• Changes in respiratory and cardiovascular systems - increased heart rate, stroke volume, and oxygen consumption; decreased lung volumes
• Immunologic changes – shift away from cell-mediated immunity
• These changes render pregnant women more susceptible and more severely affected by certain viral pathogens
Why are pregnant women at increased Why are pregnant women at increased risk for severe influenza illness?risk for severe influenza illness?
![Page 8: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/8.jpg)
• Effects of influenza on the fetus are unknown and difficult to predict
• In seasonal influenza, viremia is believed to occur infrequently and placental transmission appears to be rare – may differ with novel influenza strains
• Hyperthermia is a risk factor for some types of birth defects and other adverse outcomes
Fetal concerns regarding influenza during pregnancy
![Page 9: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/9.jpg)
• Guidelines regarding nonpharmaceutical interventions might present special challenges
• Pregnant women will require health care access (prenatal care and delivery services)
• Pregnant women might be reluctant to comply with recommendations because of concerns about fetus
Special Health Care Delivery Challenges for Pregnant Women
![Page 10: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/10.jpg)
Lu et al., Vaccine 26:1786-93, 2008
Data from National Health Interview Survey
Influenza Vaccination Coverage among Influenza Vaccination Coverage among Recommended Adult Populations, National Recommended Adult Populations, National
Health Interview Survey, 1989-2005Health Interview Survey, 1989-2005
![Page 11: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/11.jpg)
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, N Engl J Med 361, 2009
![Page 12: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/12.jpg)
Pandemic (H1N1) 2009 Influenza
• Illness resulted from quadruple reassortment virus of human, avian and swine influenza virus genes
• Viruses susceptible to oseltamivir and zanamivir, resistant to amantadine and rimantadine
• Median age – 20 years, range 3 months to 81 years; 60% were 18 years or younger (based on 642 confirmed cases reported 4/15-5/5/2009)
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, N Engl J Med 361, 2009CDC, MMWR Morb Mortal Wkly Rep 58:536-41, 2009 and 58:497-500, 2009
![Page 13: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/13.jpg)
Pandemic (H1N1) 2009 Influenza (continued)
• In the US, most confirmed cases characterized by self-limited, uncomplicated febrile respiratory illness: similar to seasonal influenza (cough, sore throat, rhinorrhea, headache, and myalgia) – 38% with vomiting or diarrhea (based on 642 confirmed cases reported 4/15-5/5/2009)
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, N Engl J Med 361, 2009CDC, MMWR Morb Mortal Wkly Rep 58:536-41, 2009 and 58:497-500, 2009
![Page 14: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/14.jpg)
Jamieson DJ et al., Lancet 374:451-8, 2009
![Page 15: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/15.jpg)
Pandemic (H1N1) 2009 Influenza and Pregnancy
Jamieson DJ et al., Lancet 374:451-8, 2009
• 34 confirmed or probable cases of pandemic (H1N1) 2009 influenza in pregnant women (April 15-May 18, 2009) in US (34/5469 or 0.62% of total)
• 11 women (32%) were admitted to hospital
• 6 deaths among pregnant woman with pandemic (H1N1) 2009 influenza (April 15-June 16, 2009) (6/45 or 13% of total)
![Page 16: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/16.jpg)
Presenting manifestations N (%)
Fever 33 (97%)
Cough 32 (94%)
Rhinorrhea 20 (59%)
Sore throat 17 (50%)
Headache 16 (47%)
Shortness of breath 14 (41%)
Vomiting 6 (18%)
Diarrhea 4 (12%)
Presenting Manifestations in Pregnant Women with Pandemic (H1N1) 2009
Influenza United States, April 15 to May 18, 2009United States, April 15 to May 18, 2009
Jamieson DJ et al., Lancet 374:451-8, 2009
![Page 17: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/17.jpg)
Pregnancy Trimester at Time of Pandemic (H1N1) 2009
Influenza InfectionUnited States, April 15-May 18, 2009
9
56
26
9
0
10
20
30
40
50
60
1sttrimester
2ndtrimester
3rdtrimester
Unknown
Trimester of Pregnancy
Pe
rce
nt
Jamieson DJ et al., Lancet 374:451-8, 2009
![Page 18: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/18.jpg)
PopulationAdmission Rate per
100,000 (95% CI)
Pregnant women 0.32 (0.13-0.52)
General Population 0.076 (0.07-0.09)
Admission Rates for Pregnant Women and General Population with
Pandemic (H1N1) 2009 Influenza United States, April 15 to May 18, 2009United States, April 15 to May 18, 2009
Jamieson DJ et al., Lancet 374:451-8, 2009
Risk Ratio 4.3, 95% CI 2.3-7.8
![Page 19: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/19.jpg)
Case #
Age (years)
Weeks’ gestation
Underlying Medical Conditions
1 33 35 Mild asthma, psoriasis
2 24 32 Obesity
3 20 27 None
4 21 11 Factor V Leiden deficiency
5 22 36 None
6 30 30 None
Deaths in Pregnant Women due to Pandemic (H1N1) 2009 Influenza
United States, April 15 to June 16, 2009United States, April 15 to June 16, 2009
Jamieson DJ et al., Lancet 374:451-8, 2009
![Page 20: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/20.jpg)
Additional Clinical Information on Deaths among Pregnant Women
• All patients developed primary viral pneumonia with subsequent ARDS requiring mechanical ventilation
• Pregnancy outcomes: 5 with cesarean delivery (27-36 weeks gestation – 3 in ICU or ED), 1 fetal loss at 11 weeks
• Length of time from symptom onset to receipt of antiviral medication was 6-15 days (median 9)
• Length of time from presentation for medical care until receipt of antiviral treatment was 2-14 days (median 4.5)
![Page 21: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/21.jpg)
Updated Information on Deaths among Pregnant Women
• ~ 5% of deaths in US from pandemic (H1N1) 2009 Influenza are among pregnant women (based on 484 H1N1 deaths reported to CDC by August 20, 24 of whom were pregnant)
• Pregnant women ~1% of the general population
![Page 22: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/22.jpg)
Infection Control in Obstetric Settings: General Principles
• Keep pregnant outpatients and inpatients separated from ill and potentially ill patients
• Requires system for rapidly assessing influenza-like symptoms and triaging patients
![Page 23: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/23.jpg)
Considerations regarding novel H1N1 in obstetric settings (July 6, 2009)
• Place surgical mask on ill mother during labor & delivery, if tolerable
• Mother should consider avoiding close contact with infant until:– antiviral medication for 48 hours– fever has fully resolved– she can control coughs and secretions
• When in contact with the infant, mother should do following until 7 days after symptom onset and symptom-free for 24 hours:– wear a facemask– change to clean gown or clothing– adhere to strict hand hygiene and cough etiquette
![Page 24: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/24.jpg)
CDC Interim Guidelines
• Testing for 2009 H1N1 influenza
• Antiviral treatment and prophylaxis
• Seasonal and 2009 H1N1 influenza vaccination
![Page 25: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/25.jpg)
Influenza Diagnostic Testing
Test MethodTime to Process
Sensitivity for 2009
H1N1
Distinguishes 2009 H1N1?
Rapid influenza diagnostic tests
Antigen detection
0.25 hour
10-70% No
Direct and indirect immunofluorescence assays (DFA/IFA)
Antigen detection
2-4 hours
47-93% No
Nucleic acid amplification tests (e.g., rRT-PCR*)
RNA detection
48-96 hours
86-100% Yes
Virus isolation in tissue cell culture
Virus isolation
2-10 days
-- Yes
http://www.cdc.gov/flu/professionals/diagnosis/0809testingguide.htm www.cdc.gov/h1n1flu/guidance/rapid_testing.htm
*rRT-PCR – real-time reverse transcriptase polymerase chain reaction
![Page 26: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/26.jpg)
Testing and Treatment
• Treatment is recommended for pregnant women with suspected or confirmed influenza, regardless of trimester of pregnancy
• Do not delay treatment because of a negative rapid influenza diagnostic test or inability to test or while awaiting test results
![Page 27: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/27.jpg)
Treatment
• Oseltamivir (Tamiflu®)– 75 mg po bid for 5 days– BEST if started within 48 hours of symptom
onset
• Oseltamivir (Tamiflu®) and zanamivir (Relenza®) are FDA pregnancy category C– Available data suggest not human teratogens
Tanaka et al. CMAJ 181:55-8, 2009
• Considering severity of disease, treatment benefit outweighs potential risk
• Acetaminophen for fever
![Page 28: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/28.jpg)
Treatment
• Rapid access to antiviral medications is essential
• Actions that might reduce delays in treatment initiation– Informing pregnant women of signs and symptoms
of influenza and need for early treatment – Ensuring rapid access to telephone consultation
and clinical evaluation – Considering empiric treatment of patients at higher
risk for influenza complications based on telephone contact
![Page 29: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/29.jpg)
Post-exposure Chemoprophylaxis
• Consider if close contact with suspected or confirmed case
• Zanamivir (Relenza®) Two 5mg inhalations qd
• Oseltamivir (Tamiflu®) 75 mg qd
• 10 day duration
• Close monitoring and early treatment is an alternative to chemoprophylaxis
![Page 30: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/30.jpg)
Post-exposure Chemoprophylaxis
• Close contact: defined as having cared for or lived with a person who is a confirmed, probable, or suspected case of influenza, or having been in a setting where there was a high likelihood of contact with respiratory droplets and/or body fluids of such a person
• Examples– sharing eating or drinking utensils – physical examination– any other contact between persons likely to result in
exposure to respiratory droplets
![Page 31: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/31.jpg)
ACIP Recommendations for Seasonal Flu Vaccination
• Influenza vaccine is recommended for people at increased risk of severe infection, including women who will be pregnant during influenza season
• This includes all pregnant women in any trimester
![Page 32: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/32.jpg)
Need for Seasonal Flu Vaccine
• Pregnant women who get influenza are at higher risk for serious complications
• Influenza vaccine given during pregnancy prevents febrile respiratory illness in pregnant women and infants and lab-proven influenza in infants up to 6 months of age
Zaman et al., NEJM 359:1555-64, 2008
![Page 33: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/33.jpg)
ACIP Recommendations for 2009 H1N1 Vaccination
• Pregnant women • Household contacts and caregivers for children
younger than 6 months of age • Healthcare and emergency medical services
personnel • All people from 6 months through 24 years of
age • Persons aged 25 through 64 years who have
health conditions associated with higher risk of influenza-related complications
![Page 34: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/34.jpg)
Need for 2009 H1N1 Vaccine
• Pregnant women who get 2009 H1N1 influenza at higher risk for hospitalization, severe illness and death
• Seasonal flu vaccine not expected to protect against 2009 H1N1 influenza
Jamieson DJ et al., Lancet 374:451-8, 2009
![Page 35: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/35.jpg)
Vaccine Types
• Live attenuated vaccine (not licensed for use in pregnant women)
• Multidose inactivated vaccine
• Prefilled single dose inactivated vaccine (preservative-free)
![Page 36: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/36.jpg)
When to Administer
• Can be given at any time during pregnancy
• Can also be given postpartum, providing indirect protection for infants <6 months
• Recommended even for women who have had influenza-like illness
![Page 37: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/37.jpg)
How to Administer
• Inactivated vaccines against seasonal flu and 2009 H1N1 can be administered simultaneously – Use different anatomic sites
• 2009 H1N1 vaccine - ancillary supplies will also be provided (needles, syringes, sharps containers, alcohol swabs, vaccination record card)
• 2009 H1N1 vaccine approved by FDA– One dose for persons > 10 years of age
![Page 38: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/38.jpg)
How to Obtain 2009 H1N1 Vaccine
• Vaccine expected to be available in October
• CDC will allocate vaccine to states based on population
• States will determine where vaccine will be shipped (mix of public and private settings)
• Contact state health department to express interest in receiving vaccine (list of contacts on CDC website)
![Page 39: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/39.jpg)
2009 H1N1 Vaccine Financing
• Vaccine available at no-cost for providers
• Providers CANNOT charge a fee for vaccine since it is being provided free of charge by the federal government
• Providers can bill insurance or charge the patient a vaccine administration fee
– Patient cannot be charged more than regional Medicare vaccine administration fee
![Page 40: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/40.jpg)
2009 H1N1 Vaccine Financing (continued)
• Providers are encouraged to vaccinate under- or uninsured patients
• If unable, providers should refer these patients to public health settings
![Page 41: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/41.jpg)
2009 H1N1 Vaccine Safety
• Anticipated to be similar to seasonal flu vaccine
• Clinical trials in pregnant women began mid-September
![Page 42: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/42.jpg)
CDC Interim Guidelines
• http://www.cdc.gov/h1n1flu
• http://www.cdc.gov/h1n1flu/pregnancy/
• http://www.cdc.gov/H1N1flu/clinician_pregnant.htm
![Page 43: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/43.jpg)
Conclusions
• During an influenza pandemic, pregnant women are expected to be a high-risk population, based on the experience with previous pandemics and with seasonal influenza
• Data available thus far suggest that pregnant women are at increased risk for complications and death from 2009 H1N1 influenza
![Page 44: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/44.jpg)
Conclusions
• Pregnant women should be informed about the signs and symptoms of 2009 H1N1 influenza
• Pregnant women who present with signs and symptoms consistent with influenza should be treated empirically with oseltamivir
• Post-exposure prophylaxis with zanamivir or oseltamivir can be considered for pregnant women
![Page 45: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/45.jpg)
Conclusions
• Both seasonal and 2009 H1N1 influenza vaccines recommended for pregnant women
• 2009 H1N1 vaccine safety expected to be similar to seasonal influenza vaccine
• Providers should contact state health department to express interest in obtaining 2009 H1N1 vaccine
![Page 46: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/46.jpg)
Kevin A. Ault MD
Department of Gynecology and Obstetrics
Emory University School of Medicine
Atlanta GA USA
![Page 47: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/47.jpg)
“On the Ground” Planning
• GA State Meeting August 2009
• Most troublesome issues– Isolation of mothers with illness– Masks during labor– Planning for new H1N1 vaccine
![Page 48: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/48.jpg)
Influenza Vaccine During Pregnancy
• Pregnancy Risk Assessment and Monitoring System (PRAMS) from Georgia and Rhode Island reported in MMWR on Sept 11, 2009
• Questionnaire mailed to women 2-6 months postpartum
• GA and RI collected influenza vaccine information starting in 2004
![Page 49: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/49.jpg)
Influenza Vaccine During Pregnancy
From MMWR Sept 11, 2009
![Page 50: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/50.jpg)
Reasons given for not receiving influenza vaccination --- Pregnancy Risk Assessment
Monitoring System, Georgia, 2006
Reason Percentage
“I don’t usually get flu vaccine” 69.4 %
“My physician did not mention anything about a flu vaccine during my pregnancy”
44.5 %
“I was worried that the flu vaccination might harm my baby”
28.1 %
“I was in my first trimester during the flu season “
25.2 %
![Page 51: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/51.jpg)
Potential interventions to improve influenza vaccination rate in pregnant women
• Standing orders in office and hospital settings
• Broadcast email to all employees• Professional education at all levels • “Best practices” review with department
head by individual provider ie quality control
• Vaccine “champion”Adopted from Mouzoon et al
![Page 52: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/52.jpg)
Safety of influenza vaccination during pregnancy
• 11 studies published between 1964 and 2008 about safety of influenza vaccination during pregnancy
• None identified maternal or fetal problems with influenza vaccination
• One prospective randomized trial showed significant benefits to mothers and newborns
![Page 53: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/53.jpg)
Data from Bhat et al ’05 – seasonal flu 2003-2004
![Page 54: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/54.jpg)
Laboratory-Proven Influenza in Infants WhoseMothers Received Influenza Vaccine vs Controls
Zaman et al., New Eng Journal of Medicine, 2008
![Page 55: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/55.jpg)
Thank you!
![Page 56: COCA Conference Call – National Obstetric Grand Rounds: Pandemic (H1N1) 2009 Influenza and Pregnancy The findings and conclusions in this report are those](https://reader035.vdocuments.us/reader035/viewer/2022070415/56649cb15503460f94976614/html5/thumbnails/56.jpg)
Continuing Education Credit/Contact Hours for COCA Conference Calls
• Continuing Education guidelines require that the attendance of all who participate in COCA Conference Calls be properly documented. ALL Continuing Education credits/contact hours (CME, CNE, CEU and CECH) for COCA Conference Calls are issued online through the CDC Training & Continuing Education Online system http://www2a.cdc.gov/TCEOnline/.
• Those who participate in the COCA Conference Calls and who wish to receive continuing education and will complete the online evaluation by August 14, 2009 will use the course code EC1265. Those who wish to receive continuing education and will complete the online evaluation between August 15, 2009 and July 15, 2010 will use course code WD1265. CE certificates can be printed immediately upon completion of your online evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through the CDC Training & Continuing Education Online System will be maintained for each user.